This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997 Jul;25(7):1095-100.

doi: 10.1097/00003246-199707000-00001.

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

F Zeni, B Freeman, C Natanson

PMID: 9233726
DOI: 10.1097/00003246-199707000-00001

Review

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

F Zeni et al. Crit Care Med. 1997 Jul.

. 1997 Jul;25(7):1095-100.

doi: 10.1097/00003246-199707000-00001.

Authors

F Zeni, B Freeman, C Natanson

PMID: 9233726
DOI: 10.1097/00003246-199707000-00001

No abstract available

PubMed Disclaimer

Comment on

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M. Opal SM, et al. Crit Care Med. 1997 Jul;25(7):1115-24. doi: 10.1097/00003246-199707000-00010. Crit Care Med. 1997. PMID: 9233735 Clinical Trial.

Similar articles

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M. Opal SM, et al. Crit Care Med. 1997 Jul;25(7):1115-24. doi: 10.1097/00003246-199707000-00010. Crit Care Med. 1997. PMID: 9233735 Clinical Trial.
Sepsis therapy trials. Continued disappointment or reason for hope?
Abraham E, Raffin TA. Abraham E, et al. JAMA. 1994 Jun 15;271(23):1876-8. doi: 10.1001/jama.271.23.1876. JAMA. 1994. PMID: 8196148 No abstract available.
Effects of recombinant interleukin-1-receptor antagonist.
Barriere SL, Pribble JP. Barriere SL, et al. Am J Hosp Pharm. 1994 May 1;51(9):1253, 1257. Am J Hosp Pharm. 1994. PMID: 8042646 No abstract available.
Interleukin-1 receptor antagonist as therapy for inflammatory disorders.
Freeman BD, Buchman TG. Freeman BD, et al. Expert Opin Biol Ther. 2001 Mar;1(2):301-8. doi: 10.1517/14712598.1.2.301. Expert Opin Biol Ther. 2001. PMID: 11727537 Review.
Glucocorticoid administration in sepsis and septic shock: time for a paradigm change?
Antonucci E, Fiaccadori E, Taccone FS, Vincent JL. Antonucci E, et al. Minerva Anestesiol. 2014 Sep;80(9):1058-62. Epub 2014 Jun 27. Minerva Anestesiol. 2014. PMID: 24971687 Review.

See all similar articles

Cited by

Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia.
Urner M, Schläpfer M, Herrmann IK, Hasler M, Schimmer RR, Booy C, Roth Z'graggen B, Rehrauer H, Aigner F, Minshall RD, Stark WJ, Beck-Schimmer B. Urner M, et al. Clin Exp Immunol. 2015 Sep;181(3):468-79. doi: 10.1111/cei.12648. Epub 2015 Jul 7. Clin Exp Immunol. 2015. PMID: 25925908 Free PMC article.
Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options.
Pei F, Gu B, Miao SM, Guan XD, Wu JF. Pei F, et al. Chin J Traumatol. 2024 Mar;27(2):63-70. doi: 10.1016/j.cjtee.2023.11.001. Epub 2023 Nov 8. Chin J Traumatol. 2024. PMID: 38040590 Free PMC article. Review.
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
Fara A, Mitrev Z, Rosalia RA, Assas BM. Fara A, et al. Open Biol. 2020 Sep;10(9):200160. doi: 10.1098/rsob.200160. Epub 2020 Sep 23. Open Biol. 2020. PMID: 32961074 Free PMC article. Review.
Genetic polymorphisms in the endotoxin receptor may influence platelet count as part of the acute phase response in critically ill children.
Agbeko RS, Holloway JW, Allen ML, Ye S, Fidler KJ, Pappachan J, Goldman A, Pontefract D, Deanfield J, Klein NJ, Peters MJ. Agbeko RS, et al. Intensive Care Med. 2010 Jun;36(6):1023-32. doi: 10.1007/s00134-010-1857-x. Epub 2010 Mar 18. Intensive Care Med. 2010. PMID: 20237756
Effects of Hydrocortisone on Regulating Inflammation, Hemodynamic Stability, and Preventing Shock in Severe Sepsis Patients.
Zhao Y, Ding C. Zhao Y, et al. Med Sci Monit. 2018 May 30;24:3612-3619. doi: 10.12659/MSM.906208. Med Sci Monit. 2018. PMID: 29845974 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information